| 臺大學術典藏 |
2019 |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Ho Y.-L.; Chang Y.-L.; Chang C.-H.; Wu C.-H.; Er L.K.; Wang W.-J.; Lin J.-H.; Lin Y.-H.; Wu V.-C.; Jeff Chueh S.-C.; Tsai Y.-C.; Liao S.-C.; Chan C.-K.; Chang C.-C.; Hu Y.-H.; Yu C.-C.; Huang K.-H.; Huang K.-H.;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Liao S.-C.;Tsai Y.-C.;Jeff Chueh S.-C.;Wu V.-C.;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Kao-Lang Liu;Wang S.-M.;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; Chang H.-W.; Lin L.-Y.; Hu F.-C.; KAO-LANG LIU; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2019 |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Chang H.-W.; Chang Y.-L.; Ho Y.-L.; Chang C.-H.; Er L.K.; Wu C.-H.; Wang W.-J.; Lin J.-H.; Lin Y.-H.; Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2020-06-26T03:31:26Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Shih-Cheng Liao;Tsai Y.-C.;Jeff Chueh S.-C.;Wu V.-C.;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Shih-Cheng Liao; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2020-09-23T06:22:14Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; RUOH-FANG YEN; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator; Chang C.-H.; Wu C.-H.; Er L.K.; Wang W.-J.; Lin Y.-H.; Lin J.-H.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Hu Y.-H.; Yu C.-C.; Huang K.-H. |
| 臺大學術典藏 |
2020-09-30T08:12:06Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator; Wang S.-M.; CHING-CHU LU; Liu K.-L.; Hu F.-C.; Chang H.-W.; Lin L.-Y.; Chang Y.-L.; Ho Y.-L.; Chang C.-H.; Er L.K.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Liao S.-C.; Chan C.-K.; Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C. |
| 臺大學術典藏 |
2020-12-04T07:44:36Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator; Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Liu K.-L.; Wang S.-M. |
| 臺大學術典藏 |
2020-12-23T02:57:02Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Liao S.-C.;Tsai Y.-C.;Jeff Chueh S.-C.;Vin-Cent Wu;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; TAIPAI, Taiwan Primary Aldosteronism Investigator; Wu K.-D.; Lu C.-C.; Yen R.-F.; Wang S.-M.; Liu K.-L.; Hu F.-C.; Lin L.-Y.; Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; VIN-CENT WU; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W. |
| 臺大學術典藏 |
2021-01-28T02:02:48Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Kuo-How Huang;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Liao S.-C.;Tsai Y.-C.;Jeff Chueh S.-C.;Wu V.-C.;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; KUO-HOW HUANG; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2021-02-01T07:30:23Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Liao S.-C.;Tsai Y.-C.;Jeff Chueh S.-C.;Wu V.-C.;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Shuo-Meng Wang;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; SHUO-MENG WANG; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2022-01-03T05:49:22Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; SHIH-CHIEH CHUEH; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2021-11-30T04:53:36Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; VIN-CENT WU; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2021-08-24T08:01:28Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; CHIEH-KAI CHAN; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2022-09-06T02:41:58Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 國立臺灣大學 |
2015 |
Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model
|
Chen, Wei-Tsung; Kang, Shih-Tsung; Lin, Jian-Liang; Wang, Chung-Hsin; Chen, Ran-Chou; Yeh, Chih-Kuang |
| 亞洲大學 |
2019-01 |
Targeted Ubiquitin-Proteasomal Proteolysis Pathway in Chronic Social Defeat Stress
|
Li, Hsiao-Yun;Lin, Hsiao-Yun;Liu, Yu-Shu;Liu, Yu-Shu;Liu, Yu-Ching;Liu, Yu-Ching;Ch, Chao-Jung;Chen, Chao-Jung;盧大宇;Lu, Dah-Yuu |
| 中山醫學大學 |
2020 |
Targeting a cysteine protease from a pathobiont alleviates experimental arthritis
|
Peng, HY; Chen, SY; Siao, SH; Chang, JT; Xue, TY; Lee, YH; Jan, MSO; Tsay, GJ; Zouali, M |
| 中山醫學大學 |
2020-05 |
Targeting a cysteine protease from a pathobiont alleviates experimental arthritis
|
Hsin-Yi Peng;Shih-Yao Chen;Shih-Hong Siao;Jinghua Tsai Chang;Ting-Yin Xue;Yi-Hsuan Lee;Ming-Shiou Jan;Gregory J. Tsay;Moncef Zouali |
| 國立成功大學 |
2020 |
Targeting a cysteine protease from a pathobiont alleviates experimental arthritis
|
Peng, H.-Y.;Chen, S.-Y.;Siao, Siao S.-H.;Chang, J.T.;Xue, T.-Y.;Lee, Y.-H.;Jan, M.-S.;Tsay, G.J.;Zouali, M. |
| 國立成功大學 |
2014-04-08 |
Targeting a Novel KRAS-Integrin-Linked Kinase Regulatory Circuitry in Pancreatic Cancer
|
Chu, Po-Chen; Yang, Ming-Chen; Samuel K. Kulp; Chen, Ching-Shih |
| 國立成功大學 |
2014-10-01 |
Targeting a novel kras-integrin-linked kinase regulatory circuitry in pancreatic cancer
|
Chu, Po-Chen; Yang, Ming-Chen; Kulp, Samuel K.; Chen, Ching-Shih |
| 國家衛生研究院 |
2015-02 |
Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: An identification of a novel oncotarget
|
Qiu, YQ;Yang, CW;Lee, YZ;Yang, RB;Lee, CH;Hsu, HY;Chang, CC;Lee, SJ |
| 國家衛生研究院 |
2019-08-06 |
Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: An identification of a novel oncotarget[Erratum: Oncotarget. 2015 Feb;6(4):2148-2163.]
|
Qiu, YQ;Yang, CW;Lee, YZ;Yang, RB;Lee, CH;Hsu, HY;Chang, CC;Lee, SJ |
| 國立成功大學 |
2024--DEC |
Targeting acetylated high mobility group box 1 protein (HMGB1) and toll-like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose-fed rats
|
Lin;Yu-Te;Ho;Chiu-Yi;Sun;Gwo-Ching;Wong;Tzyy-Yue;Hsiao;Michael;Tseng;Ching-Jiunn;Cheng;Pei-Wen |
| 國家衛生研究院 |
2012-12 |
Targeting Akt signaling for treatment of advanced prostate cancer cells with caffeic acid phenethyl ester
|
Chuu, CP;Lin, HP;Su, LC;Lin, CY;Huo, C;Kuo, YY;Chu, SC |
| 嘉南藥理大學 |
2023 |
Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG x CD20)
|
Chen, Huei-Jen; Cheng, Yi-An; Chen, Yu-Tung; Li, Chia-Ching; Huang, Bo-Cheng; Hong, Shih-Ting; Chen, I. -Ju; Ho, Kai-Wen; Chen, Chiao-Yun; Chen, Fang-Ming; Wang, Jaw-Yuan; Roffler, Steve R.; Cheng, Tian-Lu; Wu, Dung-Ho |
